Skip to main content

Podcast

The RheumNow Week In Review EULAR18 Epilogue %286.22.18%29

The RheumNow Week In Review EULAR18 Epilogue %286.22.18%29 by Dr. Cush

RheumNow - EULAR 2018 - Day 4

RheumNow - EULAR 2018 - Day 4 by Dr. Cush

RheumNow - EULAR 2018 - Day 3

RheumNow - EULAR 2018 - Day 3 by Dr. Cush

The RheumNow Week In Review EULAR18 Abbreviated %286.15.18%29

The RheumNow Week In Review EULAR18 Abbreviated %286.15.18%29 by Dr. Cush

RheumNow - EULAR 2018 - Day 1 & Day 2

RheumNow - EULAR 2018 - Day 1 & Day 2 by Dr. Cush

The RheumNow Week In Review Baricitinib Splash %286.7.18%29

The RheumNow Week In Review Baricitinib Splash %286.7.18%29 by Dr. Cush

The RheumNow Week In Review Good News For GPA%2C CZP%2C Tofa But Not ERA %286.1.18%29

The RheumNow Week In Review Good News For GPA%2C CZP%2C Tofa But Not ERA %286.1.18%29 by Dr. Cush

The RheumNow Week In Review Methotrexate CIRT Study %285.25.18%29

The RheumNow Week In Review Methotrexate CIRT Study %285.25.18%29 by Dr. Cush

The RheumNow Week In Review Modifiable Behavior %285.18.18%29

The RheumNow Week In Review Modifiable Behavior %285.18.18%29 by Dr. Cush

The RheumNow Week In Review - Nonadherence And Astronomic Costs %285.11.18%29

The RheumNow Week In Review - Nonadherence And Astronomic Costs %285.11.18%29 by Dr. Cush

The RheumNow Week In Review Why Comorbidity Is A Lot Like The Weather %285.3.18%29

The RheumNow Week In Review Why Comorbidity Is A Lot Like The Weather %285.3.18%29 by Dr. Cush

The RheumNow Week In Review FDA Showdown For Baricitinib %284.27.18%29

The RheumNow Week In Review FDA Showdown For Baricitinib %284.27.18%29 by Dr. Cush
×